Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-010488
Filing Date
2017-11-13
Accepted
2017-11-13 16:40:24
Documents
76
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT azrx10q_sep302017.htm 10-Q 903271
2 MODIFICATION TO 12% SENIOR SECURED ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE ex10-1.htm EX-10.1 15365
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 17878
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 18361
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 6849
6 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-2.htm EX-32.2 7393
  Complete submission text file 0001654954-17-010488.txt   3363920

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT azrx-20170930.xml EX-101.INS 512924
8 XBRL TAXONOMY EXTENSION SCHEMA azrx-20170930.xsd EX-101.SCH 46167
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20170930_cal.xml EX-101.CAL 47626
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20170930_def.xml EX-101.DEF 93410
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20170930_lab.xml EX-101.LAB 241122
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20170930_pre.xml EX-101.PRE 201757
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 171196549
SIC: 2834 Pharmaceutical Preparations